MYC and lymphoma: To confirm this result, we used CRISPR/Cas9 to generate isogenic Eμ-Myc lymphoma cell lines that lack either BAK, BAX, or both of these effectors of apoptosis, as confirmed by western blotting (Fig. 2C).